Lista de obras - Maria Cristina Manara - Dominio Público Uruguay

4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.

artículo científico publicado en 2005

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

artículo científico publicado en 2018

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

artículo científico publicado en 2014

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

artículo científico publicado en 2005

Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).

artículo científico publicado en 2010

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

artículo científico publicado en 2003

CD99 acts as an oncosuppressor in osteosarcoma

artículo científico publicado en 2006

CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.

artículo científico publicado en 2014

CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin

artículo científico publicado en 2014

Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.

artículo científico publicado en 2007

Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications

artículo científico publicado en 2014

Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospects

artículo científico publicado en 2004

Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

artículo científico publicado en 2014

Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.

artículo científico publicado en 2002

Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival.

artículo científico publicado en 2011

Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.

artículo científico publicado en 2013

Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene.

artículo científico publicado en 2004

Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.

artículo científico publicado en 2012

In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type

artículo científico publicado en 2005

Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma.

artículo científico publicado en 2006

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

scientific article published on 13 December 2021

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

artículo científico publicado en 2013

Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.

artículo científico publicado en 2004

Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome

artículo científico publicado en 2009

Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid Asymmetry

artículo científico publicado en 2018

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

scientific article published on 17 February 2021

Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma

artículo científico publicado en 2005

Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.

artículo científico publicado en 2011

The expression of ccn3(nov) gene in musculoskeletal tumors

artículo científico publicado en 2002

Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents.

artículo científico publicado en 2015

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

artículo científico publicado en 2012

Lista de obras de Maria Cristina Manara

4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

CD99 acts as an oncosuppressor in osteosarcoma

CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.

CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin

Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.

Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications

Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospects

Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.

Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival.

Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.

Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene.

Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.

In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type

Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma.

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.

Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome

Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid Asymmetry

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma

Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.

The expression of ccn3(nov) gene in musculoskeletal tumors

Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents.

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy